drugset / Trial / NCT00004105

Combination Chemotherapy in Treating Patients With Advanced Cancer

NCT00004105 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase I/II trial to study the effectiveness of vinorelbine, paclitaxel, and estramustine in treating patients who have advanced cancer that has not responded to previous treatment.

Timeline

Start
1998-09
Primary completion
2003-04
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Paclitaxel Small molecule — Intravenous
Subject Vinorelbine Small molecule — Intravenous
Subject estramustine Other / unclassified — Oral

Indications